Monday, September 12, 2022

Global Economic Monitor 220913

(Introduction)

[Markets]
※   Headline CPI seen easing Tuesday
※   Bristol Myers rises on FDA approval for psoriasis drug
※   Twitter says Musk's latest attempt to scrap deal invalid
※   Indexes up: Dow 0.71%, S&P 1.06%, Nasdaq 1.27%


[Indicators]


[Lawmakers & Policies]


[News]
※   Following strong gains in recent days, Ukraine’s progress slows as it begins to consolidate control
※   The Biden administration plans next month to broaden curbs on U.S shipments to China of semiconductors used for artificial intelligence and chipmaking tools
•   디지털타임스(P1): 내년 `4대 연금`에 국민혈세 10조 지원


[Opinions]
•   Project Syndicate(Joseph E. Stiglitz, Dean Baker): The Fed Should Wait and See
•   Project Syndicate(Shashi Tharoor): India’s Long Infatuation with Russia Must End
•   FT(Gideon Rachman): The Ukraine war has reached a turning point
•   FT(Patrick Jenkins): Energy crisis should spur regulatory overhaul
•   WSJ(Editorial Board): Trade Bureaucrats Gone Wild
•   WSJ(Editorial Board): China’s Coal Power Boom
•   WSJ(Walter Russell Mead): What if Putin Uses a Nuclear Weapon in Ukraine?
•   WSJ(Paul Podolsky): The Global Economy Has Become a Battlefield
•   WSJ(Terrence R. Keeley): ESG Does Neither Much Good nor Very Well
•   Bloomberg(Editorial Board): It’s Time for Plan B on Iran
•   Bloomberg(Jonathan Levin): Is Soaring Consumer Credit Bad for US Economy?
•   Bloomberg(James Stavridis): Ukraine’s Wins Make Russian War More Dangerous
•   Bloomberg(Adrian Wooldridge): China's Surveillance State Will Be the West's Future, Too
•   매경(영주 닐슨): 세계 은행들의 눈부신 변신
•   파이낸셜뉴스(곽인찬): 론스타가 남긴 세 가지 교훈

No comments:

Post a Comment